We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01328080
First Posted: April 4, 2011
Last Update Posted: March 29, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Skin of Color Society
Information provided by (Responsible Party):
Ginette Okoye, MD, Johns Hopkins University
March 31, 2011
April 4, 2011
April 21, 2014
June 16, 2014
March 29, 2017
February 2011
August 2012   (Final data collection date for primary outcome measure)
Percentage Change in Total AKN Lesions From Baseline to Week 16. [ Time Frame: Baseline to Week 16 ]
To determine if treatment of AKN with targeted ultraviolet B radiation will improve the clinical appearance of lesions.
Resolution of AKN [ Time Frame: 16 weeks ]
Complete list of historical versions of study NCT01328080 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy
Improving Acne Keloidalis Nuchae by Inducing Matrix Metalloproteinases in Vivo Using Targeted Ultraviolet-B Irradiation
This study is being done to evaluate the effect of targeted UV-B (a component of sunlight) on the treatment of acne keloidalis nuchae (AKN, or razor bumps on the back of the neck). The investigators believe targeted UV-B is a safe and effective way to reduce the appearance of AKN.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Acne Keloidalis Nuchae
Radiation: Targeted UV-B
Daavlin Lumera phototherapy device (290-320 nm), dosed by patients' individual minimal erythema dose (MED)
  • Experimental: Targeted UV-B (Left)
    Targeted UV-B on left side of the scalp.
    Intervention: Radiation: Targeted UV-B
  • Experimental: Targeted UV-B (Right)
    Targeted UV-B on right side of the scalp.
    Intervention: Radiation: Targeted UV-B
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
11
August 2012
August 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • age 18 or over
  • male gender
  • African-American or other black ethnicity
  • current diagnosis of acne keloidalis nuchae (razor bumps on back of neck)

Exclusion Criteria:

  • allergy to lidocaine or numbing medicine
  • history of increased sensitivity to sunlight, lupus, or porphyria
  • current use of a drug that increases sensitivity to sunlight
Sexes Eligible for Study: Male
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01328080
NA_00035842
No
Not Provided
Not Provided
Ginette Okoye, MD, Johns Hopkins University
Johns Hopkins University
Skin of Color Society
Not Provided
Johns Hopkins University
February 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP